Activation of Phosphatidylinositol 3-Kinase in Cells Expressing abl Oncogene Variants

Molecular and Cellular Biology

Volumn 11, Issue 2, 1991, Pages 1107-1113

  Varticovski, Lyuba ^a   Daley, George Q ^b   Jackson, Peter ^b   Baltimore, David ^b   Cantley, Lewis C ^c  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYOMAVIRUS; ANIMALIA;

PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL TRANSFORMATION; ENZYME ACTIVATION; GENE EXPRESSION; MITOGENESIS; MOUSE; MYRISTYLATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMAL; CELL LINE; CELL MEMBRANE; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; GENES, ABL; MICE; ONCOGENE PROTEINS V-ABL; PHOSPHOTRANSFERASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VARIATION (GENETICS);

EID: 0025967280     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.11.2.1107     Document Type: Article

References (47)

1. Auger, K. R., L. A. Serunian, S. P. Soltoff, P. Libby, and L. Cantley. 1989. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57:167-175.
2. Bishop, J. M., and H. E. Varmus. 1984. Functions and origins of retroviral transforming genes. p. 999-1108. In R. Weiss, N. Teich, H. Varmus, and J. Coffin (ed.), RNA tumor viruses, vol. 1. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
3. Carpenter, C. L., and L. C. Cantley. Biochemistry, in press.
4. Carpenter, C. L., B. C. Duckworth, K. R. Auger, B. Cohen, B. S. Schaffhausen, and L. C. Cantley. 1990. Purification and characterization of PI 3-kinase from rat liver. J. Biol. Chem. 265:19704-19711.
5. Chen, W. C., C. S. Lazar, M. Poenie, R. Y. Tsein, G. N. Gill, and M. G. Rosenfeld. 1987. Requirements for intrinsic protein tyrosine kinase in the immediate and late actions of EGF receptor. Nature (London) 328:820-823.
6. Chou, C. K., T. J. Dull, D. S. Russel, R. Gherzi, D. Lebwohl, A. Ullrich, and O. M. Rosen. 1987. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J. Biol. Chem. 262:1842-1847.
7. scr myristylation and membrane association and for cell transformation. Mol. Cell. Biol. 4:1834-1842.
8. Daley, G. Unpublished data.
9. Daley, G., and D. Baltimore. 1988. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210 bcr/abl protein. Proc. Natl. Acad. Sci. USA 85:9312-9316.
10. Daley, G. Q., J. McLaughlin, O. N. Witte, and D. Baltimore. 1987. The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science 237:532-535.
11. Escobedo, J. A., P. J. Barr, and L. T. Williams. 1988. Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor. Mol. Cell. Biol. 8:5126-5131.
12. scr protein. Mol. Cell. Biol. 9:1651-1658.
13. Fukui, Y., S. Kornbluth, S.-M. Jong, L.-H. Wang, and H. Hanafusa. 1989. Phosphatidylinositol kinase type I activity associates with various oncogene products. Oncogene Res. 4:283-292.
14. scr in NY68-infected cells correlates with increased tyrosine phosphorylation of membrane-associated proteins. Virology 126:73-86.
15. Honegger, A. M., T. J. Dull, S. Felder, E. Van Obberghen, F. Bellot, D. Szapary, A. Schmidt, A. Ullrich, and J. Schlessinger. 1988. Kinetic parameters of the protein tyrosine kinase activity of the EGF receptor mutants with individually altered autophosphorylation sites. EMBO J. 7:3053-3060.
16. Hunter, T., and J. A. Cooper. 1985. Protein-tyrosine kinases. Annu. Rev. Biochem. 54:897-930.
17. Jackson, P., and D. Baltimore. 1989. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8:449-456.
18. Jackson, P., and D. Baltimore. Unpublished data.
19. scr prevents both myristoylation and morphologic transformation. Proc. Natl. Acad. Sci. USA 82: 4625-4628.
20. Kamps, M. P., S. S. Taylor, and B. M. Sefton. 1984. Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinase have homologous ATP-binding sites. Nature (London) 310:589-591.
21. Kaplan, D., M. Whitman, B. Schaffhausen, D. C. Pallas, M. White, L. Cantley, and T. Roberts. 1987. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidyinositol kinase activity. Cell 50:1021-1029.
22. Kazlauskas, A., and J. A. Cooper. 1989. Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 58:1121-1133.
23. Kazlauskas, A., C. Ellis, T. Pawson, and J. A. Cooper. 1990. Binding of GAP to activated PDGF receptors. Science 247: 1578-1581.
24. Lips, D. L., P. W. Majerus, F. R. Gorga, A. T. Young, and T. L. Benjamin. 1989. PI 3-phosphate is present in normal and transformed fibroblasts and is resistant to hydrolysis by bovine brain phospholipase C II. J. Biol. Chem. 264:8759-8763.
25. Lugo, T. G., and O. N. Witte. 1989. The bcr-abl oncogene transforms rat-1 cells and cooperates with v-myc. Mol. Cell. Biol. 9:1263-1270.
26. Margolis, B., S. G. Rhee, S. Felder, M. Mervic, R. Lyall, A. Levitzki, A. Ullrich, A. Zilberstein, and J. Schlessinger. 1989. EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signalling. Cell 57:1101-1107.
27. Mathey-Prevot, B., and D. Baltimore. 1985. Specific transforming potential of oncogenes encoding protein-tyrosine kinases. EMBO J. 4:1769-1774.
28. McLaughlin, J., E. Chianese, and O. N. Witte. 1987. In vitro transformation of immature hematopoietic cells by the P210 bcr/abl oncogene product of the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 84:6558-6562.
29. Meisenhelder, J., P.-G. Suh, S. G. Rhee, and T. Hunter. 1989. Phospholipase C-γ is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell 57:1109-1122.
30. c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 83:9768-9772.
31. Molloy, C. J., D. P. Bottaro, T. P. Fleming, M. S. Marshall, J. B. Gibbs, and S. A. Aaronson. 1989. PDGF induction of tyrosine phosphorylation of GTPase activating protein. Nature (London) 342:711-714.
32. Morrison, D., D. R. Kaplan, U. Rapp, and T. M. Roberts. 1988. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc. Natl. Acad. Sci. USA 85:8855-8859.
33. Morrison, D. K., D. R. Kaplan, J. A. Escobedo, U. R. Rapp, T. M. Roberts, and L. T. Williams. 1989. Direct activation of the serine/threonine kinase activity of raf through tyrosine phosphorylation by the PDGF b-receptor. Cell 58:649-657.
34. Prywes, R. 1984. Ph.D. thesis. Massachusetts Institute of Technology, Cambridge.
35. Prywes, R., J. G. Foulkes, N. Rosenberg, and D. Baltimore. 1983. Sequences of the A-MuLV protein needed for fibroblast and lymphoid cell transformation. Cell 34:569-579.
36. Ruderman, N. B., R. Kapeller, M. F. White, and L. Cantley. 1990. Activation of phosphatidylinositol 3-kinase by insulin. Proc. Natl. Acad. Sci. USA 87:1411-1415.
37. Sefton, B. M. 1986. The viral protein tyrosine kinases. Curr. Top. Microbiol. Immunol. 123:39-72.
38. Serunian, L. A., K. R. Auger, T. M. Roberts, and L. C. Cantley. 1990. Production of novel polyphosphoinositides in vivo is linked to cell transformation by polyomavirus middle T antigen. J. Virol. 64:4718-4725.
39. Serunian, L. A., M. T. Haber, T. Fukui, J. W. Kim, S. G. Rhee, J. M. Lowenstein, and L. C. Cantley. 1989. Phosphoinositides produced by PI 3-kinase are poor substrates for phospholipase C from rat liver and bovine brain. J. Biol. Chem. 264:17809-17815.
40. Sugimoto, Y., M. Whitman, L. Cantley, and R. L. Erickson. 1984. Evidence that Rous sarcoma virus transforming gene product phosphorylates phosphatidylinositol and diacylglycerol. Proc. Natl. Acad. Sci. USA 81:2117-2121.
41. Van Etten, R. A., P. Jackson, and D. Baltimore. 1989. The type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669-678.
42. Varticovski, L., B. Drucker, D. Morrison, L. Cantley, and T. Roberts. 1989. The colony stimulating factor-1 receptor associates and activates phosphatidylinositol-3 kinase. Nature (London) 342:699-702.
43. Wahl, M. I., T. O. Daniel, and G. Carpenter. 1988. Antiphosphotyrosine recovery of phopsholipase C activity after EGF treatment of A431-cells. Science 241:968-969.
44. gag-fps modulates its biological activity. Cell 37:559-568.
45. Whitman, M., D. Kaplan, T. Roberts, and L. Cantley. 1987. Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Biochem. J. 247:165-174.
46. Whitman, M., D. R. Kaplan, B. Schaffhausen, L. Cantley, and T. M. Roberts. 1985. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature (London) 315:239-242.
47. Yamamoto, K., A. Graziani, C. L. Carpenter, L. Cantley, and E. Lapetina. J. Biol. Chem., in press.